|
Source: GENETIC LITERACY PROJECT, 4/10/18
[Editor's note: This is the first of a multi-part series on US biotech regulations and potential reform. In future installments, we'll look at biotech animal breeding, New Breeding Techniques (NBTs), biotech pharmaceutical and industrial products, and international comparisons and regulatory reform.] The first thing to understand about biotech regulation in the US is that it was not established through legislation, but rather through executive branch rulemaking under existing laws. In a series of cludge maneuvers, some more arbitrary than others as we’ll see, various categories of products and potential risks were assigned to be regulated under laws already on the books.
For more of this story, click here.
|